[1] Lord GM,Tagore R,Cook T,et al.Nephropathy caused by Chinese herbs in the UK[J].The Lancet,1999,354(9177):481-482. [2] Okada M.Chinese-herb nephropathy[J].The Lancet,1999,354(9191):1732. [3] Laing C,Hamour S,Sheaff M,et al.Chinese herbal uropathy and nephropathy[J].The Lancet,2006,368(9532):338. [4] Grant A,Ma B-Y,Chen HY. "Chinese herbal uropathy and nephropathy"?[J].The Lancet,2006,368(9545):1416. [5] Debelle FD,Vanherweghem JL,Nortier JL.Aristolochic acid nephropathy:a worldwide problem[J].Kidney Int,2008,74(2):158-169. [6] Grollman AP,Jelakovic B.Role of environmental toxins in endemic (Balkan) nephropathy.October 2006,Zagreb,Croatia[J].J Am Soc Nephrol,2007,18(11):2817-2823. [7] Stiborova M,Frei E,Arlt VM,et al.Metabolic activation of carcinogenic aristolochic acid,a risk factor for Balkan endemic nephropathy[J].Mutat Res,2008,658(1-2):55-67. [8] De Broe ME.Chinese herbs nephropathy and Balkan endemic nephropathy:toward a single entity,aristolochic acid nephro-pathy[J].Kidney Int,2012,81(6):513-515. [9] Chen CH,Dickman KG,Moriya M,et al.Aristolochic acid-associated urothelial cancer in Taiwan[J].Proc Natl Acad Sci USA,2012,109(21):8241-8246. [10] Chen CH,Dickman KG,Huang CY,et al.Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan:clinical characteristics and outcomes[J].Int J Cancer,2013,133(1):14-20. [11] Attaluri S,Bonala RR,Yang IY,et al.DNA adducts of aristolochic acid Ⅱ:total synthesis and site-specific muta-genesis studies in mammalian cells[J].Nucleic Acids Res,2010,38(1):339-352. [12] Nortier JL,Martinez MC,Schmeiser HH,et al.Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)[J].New Engl J Med,2000,342(23):1686-1692. [13] Arlt VM,Alunni-Perret V,Quatrehomme G,et al.Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer[J].Int J Cancer,2004,111(6):977-980. [14] Mei N,Arlt VM,Phillips DH,et al.DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver[J].Mutat Res,2006,602(1/2):83-91. [15] Wooltorton E.Several Chinese herbal products may contain toxic aristolochic acid[J].CMAJ,2004,171(5):449. [16] Shibutani S,Dong H,Suzuki N,et al.Selective toxicity of aristolochic acids I and Ⅱ[M].Drug Metab Dispos,2007:1217-1222. [17] Wu K,Jiang L,Cao J,et al.Genotoxic effect and nitrative DNA damage in HepG2 cells exposed to aristolochic acid[J].Mutat Res,2007,630(1/2):97-102. [18] Yeh YH,Lee YT,Hsieh HS,et al.Short-term toxicity of aristolochic acid,aristolochic acid-I and aristolochic acid-Ⅱ in rats[J].Food Chem Toxicol,2008,46(3):1157-1163. [19] Zhao ZZ,Liang ZT,Jiang ZH,et al.Comparative study on the aristolochic acid I content of Herba Asarifor safe use[J].Phytomedicine,2008,15(9):741-748. [20] Fluckiger-Isler S,Baumeister M,Braun K,et al.Assessment of the performance of the Ames Ⅱ assay:a collaborative study with 19 coded compounds[J].Mutat Res,2004,558(1/2):181-197. [21] Kamber M,Fluckiger-Isler S,Engelhardt G,et al.Comparison of the Ames Ⅱ and traditional Ames test responses with respect to mutagenicity,strain specificities,need for metabolism and correlation with rodent carcinogenicity[J].Mutagenesis,2009,24(4):359-366. [22] Piegorsch WW,Simmons SJ,Margolin BH,et al.Statistical modeling and analyses of a base-specific Salmonella mutagenicity assay[J].Mutat Res,2000,467(1):11-19. [23] Bougeard C,Gallampois C,Brack W.Passive dosing:an approach to control mutagen exposure in the Ames fluctuation test[J].Chemosphere,2011,83(4):409-414. [24] Reifferscheid G,Maes HM,Allner B,et al.International round-robin study on the Ames fluctuation test[J].Environ Mol Mutagen,2012,53(3):185-197. [25] 邹琳,潘秀颉,吴维佳,等.微量波动Ames试验在卷烟烟气毒理学评价中的应用研究.[J].湖南农业科学,2010,11:8-48. [26] 宋芬,李彤,徐良品,等.微量波动试验方法的研究[J].中国公共卫生学报,1990,9(1):39-40. [27] International Organization for Standardization.ISO 113502012:Water quality-determination of the genotoxicity of water and waste water-Salmonella/microsome fluctuation test (Ames fluctuation test)[S/OL].[2016-07-05].http://www.iso.org. [28] Jelakovic B,Karanovic S,Vukovic-Lela I,et al.Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid[J].Kidney Int,2012,81(6):559-567. [29] Sidorenko VS,Yeo JE,Bonala RR,et al.Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts[J].Nucleic Acids Res,2012,40(6):2494-2505. [30] Slade N,Moll UM,Brdar B,et al.p53 mutations as fingerprints for aristolochic acid:an environmental carcinogen in endemic (Balkan) nephropathy[J].Mutat Res,2009,663(1/2):1-6. [31] Xing G,Qi X,Chen M,et al.Comparison of the mutagenicity of aristolochic acid I and aristolochic acid Ⅱ in the gpt delta transgenic mouse kidney[J].Mutat Res,2012,743(1/2):52-58. [32] ICH Harmonised Tripartite Guideline (M7).Assessment and control of DNA reactive (mutagenic) impurities in pharma-ceuticals to limit potential carcinogenic risk[EB/OL].[2014-07-23].htte://www.ich.org. |